|
KIAA0831 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.0359000003386E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02059999995685E-06 |
| Normal-vs-Stage2 |
2.76489999995189E-06 |
| Normal-vs-Stage3 |
3.00970000033374E-07 |
| Normal-vs-Stage4 |
9.6875999999968E-05 |
| Stage1-vs-Stage2 |
5.876600E-01 |
| Stage1-vs-Stage3 |
3.518800E-01 |
| Stage1-vs-Stage4 |
7.783400E-01 |
| Stage2-vs-Stage3 |
8.934400E-01 |
| Stage2-vs-Stage4 |
5.336400E-01 |
| Stage3-vs-Stage4 |
3.788800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.17890000048438E-07 |
| Normal-vs-AfricanAmerican |
8.015500E-03 |
| Normal-vs-Asian |
4.234000E-04 |
| Caucasian-vs-AfricanAmerican |
2.965400E-01 |
| Caucasian-vs-Asian |
1.085390E-01 |
| AfricanAmerican-vs-Asian |
9.038200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96340000000661E-05 |
| Normal-vs-Female |
1.92070000015754E-07 |
| Male-vs-Female |
5.583600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.49669999999414E-06 |
| Normal-vs-Age(41-60Yrs) |
4.23739999977357E-07 |
| Normal-vs-Age(61-80Yrs) |
2.15199999997751E-06 |
| Normal-vs-Age(81-100Yrs) |
2.4782000000001E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.494600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.342400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.130200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.058200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.160600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.657400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.588400E-02 |
| Classical-VS-Follicular |
7.002200E-03 |
| Classical-VS-Other |
7.584800E-01 |
| Classical-VS-Normal |
2.37810000000005E-05 |
| Tall-VS-Follicular |
9.892800E-01 |
| Tall-VS-Other |
3.842800E-01 |
| Tall-VS-Normal |
7.32640000000728E-07 |
| Follicular-VS-Other |
2.759400E-01 |
| Follicular-VS-Normal |
1.65899999959862E-07 |
| Other-VS-Normal |
1.317360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70930000042979E-07 |
| Normal-vs-N1 |
1.552150E-04 |
| N0-vs-N1 |
3.450400E-01 |
|
|
